Article Details

Survey puts spotlight on US neurologists' response to CMS Alzheimer drugs decision

Retrieved on: 2022-05-16 17:05:35

Tags for this article:

Click the tags to see associated articles and topics

Survey puts spotlight on US neurologists' response to CMS Alzheimer drugs decision. View article details on HISWAI: https://www.biopharma-reporter.com/Article/2022/05/16/survey-reveals-us-neurologists-response-to-cms-alzheimer-drugs-decision

Excerpt

... Medicaid Services (CMS) announced its National Coverage Determination for monoclonal antibodies against amyloid for the treatment of Alzheimer's.

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up